Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Recurrence of esophageal intestinal metaplasia after treatment of Barrett's

This month's issue of Gastroenterology examines the recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus.

News image

Radiofrequency ablation is an established treatment for dysplastic Barrett's esophagus.

Although short-term end points of ablation have been ascertained, there have been concerns about recurrence of intestinal metaplasia after ablation.

Dr Milli Gupta and colleagues from Minnesota, USA estimated the incidence and identified factors that predicted the recurrence of  intestinal metaplasia  after successful radiofrequency ablation.

The researchers analyzed data from 592 patients with Barrett's esophagus treated with radiofrequency ablation from 2003 through 2011 at 3 tertiary referral centers.

The doctors defined complete remission of intestinal metaplasia as eradication of intestinal metaplasia, documented by 2 consecutive endoscopies.

Recurrence was defined as the presence of intestinal metaplasia or dysplasia after complete remission of intestinal metaplasia  in surveillance biopsies.

There were 2 experienced gastrointestinal pathologists that confirmed pathology findings.

The doctors noted that based on histology analysis, before radiofrequency ablation, 71% of patients had high-grade dysplasia or esophageal adenocarcinoma, 15% had low-grade dysplasia, and 14% had nondysplastic Barrett's esophagus.

Of patients treated, 448 were assessed after radiofrequency ablation.

There were 55% of patients who underwent endoscopic mucosal resection before radiofrequency ablation.

22% of all recurrences observed were dysplastic Barrett's esophagus
Gastroenterology

The researchers found that the median time to complete remission of intestinal metaplasia  was 22 months, with 56% of patients in complete remission of intestinal metaplasia  by 24 months.

Increasing age and length of Barrett's esophagus segment were associated with longer times to complete remission of intestinal metaplasia.

The team noted that 24 months after complete remission of intestinal metaplasia, the incidence of recurrence was 33%.

The researchers found that 22% of all recurrences observed were dysplastic Barrett's esophagus.

The doctors noted that there were no demographic or endoscopic factors associated with recurrence.

Complications developed in 6.5% of subjects treated with radiofrequency ablation, and strictures were the most common complication.

Dr Gupta's team commented, "Of patients with Barrett's esophagus treated by radiofrequency ablation , 56% were in complete remission after 24 months."

"However, 33% of these patients had disease recurrence within the next 2 years."

"Most recurrences were nondysplastic and endoscopically manageable, but continued surveillance after Radiofrequency ablation is essential."

Gastroenterol 2013: 145(1): 79-86
12 July 2013

Go to top of page Email this page Email this page to a colleague

 24 November 2014

Advanced search
 24 November 2014 
Adhesions in abdominal and pelvic surgery
 24 November 2014 
Nasoenteric tube feeding in acute pancreatitis
 24 November 2014 
Corticosteroids and infections in elderly-onset IBD
 21 November 2014 
Skin cancer in ulcerative colitis patients
 21 November 2014 
Mortality of chemoembolization in hepatocellular carcinoma
 21 November 2014 
Hepatic involvement in IgG4-related disease
 20 November 2014 
Global measures in chronic idiopathic constipation
 20 November 2014 
Macrophage activation in alcoholic hepatitis
 20 November 2014 
Covert hepatic encephalopathy and survival
 19 November 2014 
Thiopurine withdrawal in IBD
 19 November 2014 
Esophageal narrowing in esophageal eosinophilia
 19 November 2014 
Second intestinal resection in Crohn's
 18 November 2014 
Colorectal neoplasia and vitamin D
 18 November 2014 
Food-associated changes in the intestinal mucosa in IBS
 18 November 2014 
Alternative medicine use by US adults
 17 November 2014 
Treatment of obesity in primary care settings
 17 November 2014 
Allergy-related diseases and abdominal pain in childhood
 17 November 2014 
Diagnosis of monogenic very early onset IBD
 14 November 2014 
Second intestinal resection in Crohn's
 14 November 2014 
HCC risk in active stage Hep B
 14 November 2014 
Thiopurine and clinical remission in IBD
 13 November 2014 
Antibiotics and risk of new-onset Crohn’s
 13 November 2014 
Chronic Hep C genotype 1 treatment after relapse
 13 November 2014 
Chemoembolization for hepatocellular carcinoma
 12 November 2014 
Risk of hepatocellular carcinoma
 12 November 2014 
Abdominal symptom severity in chronic idiopathic constipation
 12 November 2014 
Screening colonoscopy
 11 November 2014 
Hepatocellular carcinoma in Hep B with nucleotide analogue
 11 November 2014 
Familial colorectal cancer screening
 11 November 2014 
Fecal microbiota transplant for C. diff
 10 November 2014 
STaples IPAA for ulcerative colitis
 10 November 2014 
Blood stream infections in acute liver failure
 10 November 2014 
Ig4-related disease
 07 November 2014 
Host and viral factors in chronic Hep C
 07 November 2014 
Celiac diagnosis without biopsy
 07 November 2014 
Pricing practices of gastroenterologists
 06 November 2014 

Colorectal surgery postdischarge occurrences and readmissions

 06 November 2014 
Thromboprophylaxis in IBD
 06 November 2014 
Steatosis biomarkers in NAFLD
 05 November 2014 
Readmission risk factors for patients with IBD
 05 November 2014 
Hysterectomy and colonoscopy completion
 05 November 2014 
Adalimumab in Crohn's disease
 04 November 2014 
Gut barrier dysfunction and CNS disorders
 04 November 2014 
Hemospray for nonvariceal upper GI bleeding
 04 November 2014 
Sleep duration and ulcerative colitis
 03 November 2014 
Mucosal pathophysiology in HIV and IBD
 03 November 2014 
Managing bleeding gastroduodenal ulcers
 03 November 2014 
Identifying inflammation in ulcerative colitis
 31 October 2014 
Pregnancy complications in celiac disease
 31 October 2014 
Pediatric NAFLD
 31 October 2014 
C. difficile infection with metronidazole
 30 October 2014 
Cirrhosis in women
 30 October 2014 
Costs in newly diagnosed patients with chronic constipation
 30 October 2014 
Constipation and colorectal cancer
 29 October 2014 
Quality of life after infection with E. coli
 29 October 2014 
IBS in primary care
 29 October 2014 
Sensorimotor activity in functional dyspepsia
 28 October 2014 
Increased bile acid synthesis in IBS-diarrhea
 28 October 2014 
Successful radiofrequency ablation for Barrett’s
 28 October 2014 
Risk factor for smaller final height in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2014 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us